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Abstract
Background: Clostridium perfringens causes toxin-mediated diseases, including gas gangrene (clostridial myonecrosis)
and food poisoning in humans. The production of the toxins implicated in gas gangrene, α-toxin and perfringolysin O,
is regulated by the VirSR two-component regulatory system. In addition, RevR, an orphan response regulator, has been
shown to affect virulence in the mouse myonecrosis model. RevR positively regulates the expression of genes
that encode hydrolytic enzymes, including hyaluronidases and sialidases.
Results: To further characterize the VirSR and RevR regulatory networks, comparative transcriptomic analysis
was carried out with strand-specific RNA-seq on C. perfringens strain JIR325 and its isogenic virR and revR regulatory
mutants. Using the edgeR analysis package, 206 genes in the virR mutant and 67 genes in the revR mutant were found
to be differentially expressed. Comparative analysis revealed that VirR acts as a global negative regulator, whilst RevR
acts as a global positive regulator. Therefore, about 95 % of the differentially expressed genes were up-regulated in the
virR mutant, whereas 81 % of the differentially expressed genes were down-regulated in the revR mutant. Importantly,
we identified 23 genes that were regulated by both VirR and RevR, 18 of these genes, which included the
sporulation-specific spoIVA, sigG and sigF genes, were regulated positively and negatively by RevR and VirR,
respectively. Furthermore, analysis of the mapped RNA-seq reads visualized as depth of coverage plots showed that
there were 93 previously unannotated transcripts in intergenic regions. These transcripts potentially encode
small RNA molecules.
Conclusion: In conclusion, using strand-specific RNA-seq analysis, this study has identified differentially expressed
chromosomal and pCP13 native plasmid-encoded genes, antisense transcripts, and transcripts within intergenic
regions that are controlled by the VirSR or RevR regulatory systems.
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Background
Clostridium perfringens is a Gram-positive, spore-
forming anaerobic rod that is ubiquitous in the environ-
ment and is found in the gastrointestinal tract of
humans and animals [1, 2]. It causes a wide range of
diseases in humans, such as clostridial myonecrosis or
gas gangrene, food poisoning and necrotizing entero-
colitis. In animals it causes lamb dysentery, ovine en-
terotoxemia and avian necrotic enteritis [1, 3]. These
diseases are primarily toxin-mediated and the toxin
genes can be either chromosomal or plasmid-encoded
[4]. For example, in gas gangrene strains, the major
toxin genes plc (α-toxin) and pfoA (perfringolysin O or
θ-toxin) are chromosomally encoded, whilst in animal
isolates, the β-toxin, ε-toxin, ι-toxin and NetB toxin
genes are present on plasmids [4].
Of the 20 known toxins or hydrolytic enzymes pro-
duced by C. perfringens [2, 5, 6], α-toxin and perfringo-
lysin O are the primary virulence factors involved in
the pathogenesis of gas gangrene [7, 8]. Extracellular
hydrolytic enzymes such as sialidases (NanI and NanJ)
have also been implicated in disease and postulated to
modulate the effect of α-toxin [9]. Furthermore, these
enzymes have been proposed to act as spreading factors
that destroy the physical properties of tissue matrices
and intercellular spaces, thereby aiding in the spread of
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bacteria within the host [10]. However, mutations in
the nanI and nanJ genes did not affect virulence in the
mouse myonecrosis model [11].
The production of α-toxin, perfringolysin O and some
extracellular enzymes is regulated by the VirSR two-
component system [12, 13], small regulatory RNA mole-
cules (sRNAs) [13, 14], and the RevR orphan response
regulator [15]. The VirSR regulatory system is a typical
two-component signal transduction system consisting of
the membrane-bound sensor histidine kinase, VirS, and
the cytoplasmic response regulator, VirR [12, 16]. In re-
sponse to an appropriate quorum sensing signal, which
has been proposed to be an Agr-like autoinducing pep-
tide [17, 18], VirS is autophosphorylated. The phos-
phoryl group is then transferred to a conserved aspartate
residue (D57) in VirR. Once phosphorylated, VirR dir-
ectly stimulates or represses target gene expression by
binding to two imperfect direct repeats, called VirR
boxes, which are located upstream of the target genes
[19, 20]. Genes that encode perfringolysin O (pfoA), α-
clostripain (ccp) and three sRNAs (vrr, virT, and virU)
are the only genes known to have upstream VirR boxes
in C. perfringens strain 13 [14, 20, 21]. Of the sRNAs,
the best studied is VR-RNA (encoded by vrr), which acts
as a secondary regulatory molecule that controls the ex-
pression of 147 genes, including chromosomally encoded
genes such as plc and colA (encoding κ-toxin), as well as
the pCP13 encoded genes, cpb2 (encoding β2-toxin) and
cnaB (encoding a putative collagen adhesion) [22, 23].
By contrast, VirT regulates the expression of pfoA and
ccp [14], while VirU controls the expression of pfoA, ccp,
vrr and virT [21].
RevR has been shown to modulate virulence in a
VirSR-independent manner since the expression of the
VirSR-regulated virulence-associated genes, plc and
pfoA, is unchanged in a revR mutant [15]. Sequence
alignment and structure prediction of RevR has shown
that it is similar to the response regulators PhoB from
Escherichia coli and YycF from Bacillus subtilis [15].
Since a potential winged-helix-turn helix DNA binding
domain was present within the C-terminal domain of
RevR, it was proposed that RevR controls its regulon by
binding to a DNA target [15]. Although the mechanism
of action of RevR is still unclear, microarray analysis has
revealed that RevR regulates many genes including those
encoding hydrolytic enzymes (nagL, nagH, nanI, nanJ
and ccp) and some sporulation genes. Importantly, a
revR mutant was attenuated for virulence in the
mouse myonecrosis model when compared to its
wild-type parent [15].
In this study, to further characterize the VirSR and
RevR regulatory systems, we carried out RNA-seq ana-
lysis of the C. perfringens strain JIR325, a derivative of
strain 13, and its isogenic virR and revR regulatory
mutants. Comparative strand-specific RNA-seq was used
to identify all genes, sRNA and antisense transcripts that
may be part of the VirSR or RevR regulons. These tran-
scriptome analyses revealed that VirR is a global repres-
sor and that RevR is a global activator. Importantly, VirR
and RevR regulated several common genes, but in a re-
ciprocal manner.
Methods
Bacterial strains and culture conditions
C. perfringens strain JIR325, a rifampicin and nalidixic acid
resistant derivative of strain 13 [12], and its derivatives,
JIR12364 (virRΩTTermB) and JIR12233 (ΔrevRΩerm)
[15], were used in this study. The virR mutant was con-
structed by Targetron mutagenesis using the virR Targe-
tron plasmid, pJIR3608, as outlined previously [24].
Potential mutants that had been cured of pJIR3608, but
retained the Targetron insertion, were selected and ana-
lyzed by PCR and Southern blot hybridization as de-
scribed previously [24]. One of these confirmed virR
mutants, JIR12364, was selected for further analysis.
C. perfringens broth cultures were grown overnight at
37 °C in fluid thioglycolate (FTG) medium or in TPG
broth medium (5 % (w/v) tryptone, 0.5 % (w/v) protease
peptone and 0.1 % (w/v) sodium thioglycolate) with glu-
cose added to a final concentration of 0.38 % (w/v) after
sterilization. Agar cultures of C. perfringens were grown
on nutrient agar (NA) (Oxoid or Difco, BD) supple-
mented with rifampicin (10 μg/ml), nalidixic acid
(10 μg/ml) or erythromycin (50 μg/ml) under anaerobic
conditions (10 % (v/v) H2, 10 % (v/v) CO2 and 80 % (v/v)
N2). Growth of these strains was determined by measur-
ing the optical density (OD) at 600 nm using a WPA
Biowave CO8000 cell density meter.
Isolation of total RNA
C. perfringens strains were grown at 37 °C in TPG broth
with an initial OD600 of 0.05 and cells were harvested by
centrifugation at 8000 g for 10 min at room temperature,
when the culture had reached late logarithmic phase
(5 h; OD600 of 1.8–2.0). The harvested cells were resus-
pended and incubated in lysis buffer (10 mM Tris-HCI
pH 7.5, 0.4 M sucrose, 5 mg/ml lysozyme) at 37 °C for
30 min. Following centrifugation at 16, 060 g for 10 min,
the supernatant was discarded and total RNA was iso-
lated from the cells using TRIzol® reagent (Invitrogen) as
previously described [15]. To remove contaminating
DNA, the RNA was treated with 4U of TURBO DNase
(Ambion) at 37 °C for 90 min according to the manufac-
turer’s instructions. To test for DNA contamination, the
RNA was used as a template for PCR without reverse
transcription using oligonucleotide primers for the
housekeeping gene, rpoA (Additional file 1: Table S1).
The PCR cycling conditions were as follows: 95 °C for
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5 min, followed by 30 cycles of 95 °C for 1 min, 55 °C for
1 min, and 72 °C for 1 min. RNA quality was also vali-
dated by use of a Nanodrop spectrophotometer (Thermo
Fisher) and only RNA with an absorbance at 260/280 nm
ratio of > 1.9–2.1 was used for cDNA synthesis.
PCR, reverse-transcription-PCR (RT-PCR) and quantitative
real-time PCR (QRT-PCR)
All primers used in PCR, RT-PCR and QRT-PCR are
listed in Additional file 1: Table S1. Standard PCR re-
actions were performed with Taq DNA polymerase
(New England Biolabs). PCR cycling conditions were
as shown earlier.
To examine gene expression and to validate RNA-seq
data by QRT-PCR, 2 μg of total RNA was used for first
strand cDNA synthesis using random hexamers (Pro-
mega) and AMV-reverse transcriptase (Promega). The
negative control samples were prepared by replacing
AMV-reverse transcriptase with nuclease-free water and
were labeled as NRT (no reverse transcriptase). The
reverse-transcription reaction was incubated for 1 h at
42 °C, followed by 10 min at 90 °C and 5 min on ice.
For QRT-PCR, each 25 μl reaction contained 12.5 μl
of SYBR Green mastermix (Applied Biosystems), 1 μl of
forward and reverse primers (Additional file 1: Table S1)
at a final concentration of 5 μM, 1 μl of cDNA, and the
appropriate amount of nuclease-free water. A standard
curve for each gene was generated from genomic DNA
of JIR325. PCR conditions were as follows: initial de-
naturation at 95 °C for 15 min, 40 cycles of 95 °C for
20 s, 50 °C for 30 s and 68° for 20 s. Reactions were
confirmed as being the result of a single product by
melting curve analysis. All QRT-PCRs were completed
using the Mastercycler ep Realplex real time PCR sys-
tem (Eppendorf ) and were carried out on three inde-
pendent biological replicates. The expression of each
gene was normalized against the expression of the
housekeeping gene, rpoA, from the same biological
replicate, before comparative analysis.
RNA-seq library preparation and RNA-seq analysis
Strand specific RNA-seq was carried out as before [25].
Briefly, for first strand synthesis (FSS), a 100 μl reaction
that contained 8 μg of total RNA and 15 μg of random
hexamers (Promega) was incubated at 65 °C for 5 min
and placed on ice for 5 min. The reaction was then
combined with 20 μl of 5X first strand buffer (Invitrogen),
10 μl of 100 mM of dithiothreitol (DTT) (Invitrogen), 5 μl
of 10 mM of deoxynucleotide (dNTP) mix (Promega)
and 2.5 μl of 40 U/μl RNasin (Promega) and incu-
bated at 25 °C for 2 min. Subsequently, 5 μl of 200
U/μl SuperScript III was added to the reaction and
incubated under the following conditions: 25 °C for
10 min, 42 °C for 50 min and 70 °C for 15 min. To
remove excess dNTPs the FSS reaction was purified
with a G-50 gel filtration spin column (GE Health-
care), according to the manufacturer’s instructions.
Second strand synthesis was carried out as previously
described [25], The resultant cDNA samples were
used to construct cDNA libraries, where end-repair,
A-tailing, ligation of adapter primers, size selection
and pre-amplification were carried out with the Tru-
seq RNA sample preparation kit version 1 (Illumina)
as per the manufacturer’s instructions. The cDNA li-
braries were then sequenced as 100-mers using an
Illumina Solexa GAIIx Sequencer by Micromon at
Monash University. For each strain, two independent
biological replicates were sequenced.
RNA-seq data analysis
To analyze the RNA-seq data, the read pairs firstly were
clipped of low quality regions and adaptor sequences, then
aligned to the reference genome of C. perfringens strain 13
(GeneBank accession: NC_003366 and NC_003042) using
SHRiMP alignment software (http://compbio.cs.toron-
to.edu/shrimp/). If a sequence read aligned to multiple lo-
cations on the genome, all alignments were kept for
downstream statistical analysis and were referred to as a
multi-hit read. The total number of aligned reads at each
genomic position was counted using the Nesoni software
package (http://www.vicbioinformatics.com/software.ne-
soni.shtml), a high-throughput sequencing data analysis
toolset used to generate coverage depth plots, which can
be visualized in the Artemis genome browser [26].
The mapped transcriptome data were then viewed, in
a strand-specific manner, as a graph relative to the
genome annotation.
Before analyzing the data, scatter plots of the ex-
pression levels of all genes measured by read counts
were generated using Microsoft Excel to show the
correlation and reproducibility between the biological
replicates for each strain. Spearman's rho correlation
coefficient between two replicates was then calculated
using R code [27, 28]. Transcriptomic analysis was
carried out using the Bioconductor edgeR analysis
package [27], which uses a generalized linear model
with a logarithmic link function and a negative bino-
mial error distribution in the analysis. The dispersion
parameter of the negative-binomial model was esti-
mated per gene, and moderated with a global model
of dispersion as a smoothly varying function of over-
all abundance (the "trend" option in edgeR). To
minimize false positive results, a stringent cutoff of
False Discovery Rate (FDR) <0.01 and log2 fold-
change >1 was applied when identifying differentially
expressed genes of the wild type compared to the
mutant strains (Additional file 2: Table S2 & Additional
file 3: Table S3).
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With the Bioconductor “goseq” package [29], the
differentially expressed gene lists (FDR <0.01; log2
fold-change > 1) of the virR and revR mutants were
mapped to known pathways at Kyoto Encyclopedia of
Genes and Genomes (KEGG) and Gene Ontology
(GO) [29] so that over-represented categories in the
gene lists could be identified. Finally, to determine
genes that were regulated by both VirR and RevR, the
differentially expressed gene lists were analyzed in the
Vennt program (http://www.vicbioinformatics.com/
software.vennt.shtml). Vennt generates dynamic Venn
diagrams from differential expressed gene lists, which en-
ables the identification of overlapping genes in the lists.
RNA-seq data accession number
The gene expression data have been deposited in the
NCBI Gene Expression Omnibus (GEO) database with
the GEO series accession number GSE72137.
Identification of the potential sRNAs
Many sRNA molecules are found within intergenic re-
gions of bacterial genomes [30, 31]. Therefore, using the
depth of coverage plot generated from the wild-type
transcriptomic data, active transcription with a mini-
mum length of 30 nucleotides and more than 10 reads
within intergenic regions was recorded. A total of 93
previously unannotated transcripts were identified.
These putative sRNAs were designated as SR1 to SR93
(Small RNA). These potential sRNAs included intergenic
non-coding RNAs as well as 5’untranslated regions
(UTRs), such as potential riboswitches, and 3’ UTRs.
Northern blotting analysis
For Northern blot analysis, total RNA was isolated at
hourly intervals (1 to 5 h) from wild-type cells cultured in
TPG broth at 37 °C. Hybridization probes of the selected
sRNAs were generated using the appropriate primers
(Additional file 1: Table S1). A total of 10 μg of RNA from
each time point was resolved by 1.5 % (w/v) agarose gel
electrophoresis, transferred onto a nylon membrane and
hybridized with specific probes. Northern blotting was
carried out as previously described, with some modifi-
cations [32, 33]. DNA probes were generated by PCR
using the genomic DNA of the wild type as a tem-
plate and were labeled by use of the AlkPhos-direct
kit (GE Healthcare Life Sciences). Primers used for
probe generation are listed in Additional file 1: Table
S1. Signals were detected using CDP-Star® chemilu-
minescence (Roche). The autoradiograms were devel-
oped using a BAS 2000 Bio-Imaging Analyzer (Fuji
Photo Film Co., Ltd., Kanagawa, Japan). All Northern
blot analyses were performed at least twice using in-
dependently derived RNA preparations to confirm the
reproducibility of the results.
Results
VirR acts as a global negative regulator, whilst RevR acts
as a global positive regulator
To further characterize the VirSR and RevR virulence-
related regulatory systems, we carried out strand-specific
RNA-seq analysis on the wild-type strain JIR325 and its
respective virR and revR mutants, JIR12364 and JIR12233.
RNA from each strain was extracted from cells cultured in
TPG broth for 5 h, which corresponded to late logarith-
mic growth phase. Two independent biological replicates
were sequenced for each strain. Approximately 90 % of
the reads were retained after quality and adapter clipping,
and of these reads, 97 % aligned to the strain 13 reference
genome (wild type, ca. 9.3 M read-pairs per replicate; virR
mutant, ca. 11.2 M read-pairs per replicate and revR mu-
tant, ca. 12.7 M read-pairs per replicate). Note that be-
cause the rRNA was not depleted from the total RNA
samples, many of these reads (92 %) were derived from
the rRNA transcripts. Scatter plots were generated to
demonstrate the reproducibility between the two bio-
logical replicates (Additional file 4: Figure S1A-C). With
Spearman’s rho correlation coefficients of greater than
0.928, the data were deemed to be highly reproducible.
In the virR mutant, 206 chromosomally encoded genes
were found to be differentially expressed compared to
the wild type (Additional file 2: Table S2). Of these
genes, 95 % (195) were expressed at a higher level in the
virR mutant compared to the wild type, with only 5 %
(11) having lower expression in the virR mutant (Fig. 1a).
These results indicate that VirR acts primarily as a glo-
bal transcriptional repressor. Nevertheless, VirR posi-
tively regulated the expression of 11 chromosomally
encoded genes (Additional file 2: Table S2), including
five genes (ccp, virT, virU, vrr and pfoA) with upstream
VirR boxes [20]. The six remaining genes, encoding
transporter proteins (encoded by pstC, fruA, nirC and
cpe0947), a phosphoribosymaninomidazole carboxylase
catalytic subunit (purE) and a hypothetical protein
(cpe0844) (Additional file 2: Table S2), did not contain
upstream VirR boxes.
By contrast, in the revR mutant, 67 chromosomally
encoded genes were found to be differentially expressed
(Additional file 3: Table S3). Of these genes, 81 % (54)
were expressed at a lower level in the revR mutant com-
pared to the wild type, providing evidence that RevR acts
primarily as a global transcriptional activator (Fig. 1b).
The RevR regulon included genes encoding hyaluroni-
dases (nagH, nagI, nagJ, nagL), a sialidase (nanJ), a
protease (cspB) and a transcriptional repressor (ctsR)
(Additional file 3: Table S3). Furthermore, consistent
with our previous microarray study [15], RevR enhanced
the expression of genes encoding several hydrolytic en-
zymes including NagH, NagL and NanJ (Additional file
3: Table S3). The revR and virR genes were expressed at
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levels similar to wild type in the virR and revR mutants,
respectively. In the revR mutant, the log2 fold change of
virR was 0.425 with an FDR of 0.711, while in the virR
mutant, the log2 fold change of revR was 0.0913 with an
FDR or 0.9767. The FDRs of both genes were notably
higher than the 0.01 threshold, indicating that they were
not significantly different from the levels in the wild
type. These results suggest that these genes are
expressed independently.
QRT-PCR was employed to validate the expression of
selected VirR-regulated genes (Fig. 2a). To encompass a
range of expression changes, an up-regulated gene
(cspB) and two down-regulated genes (pfoA and ccp)
were selected for validation. In agreement with the
RNA-seq data, QRT-PCR confirmed that the expression
of the pfoA and ccp genes was reduced and that
expression of cspB was increased in the virR mutant.
The expression of the plc gene was also of interest, as it
encodes the major toxin involved in gas gangrene [7].
With the stringent criteria used here (FDR < 0.01 and
fold change > 2-fold), the expression of plc was not
deemed to be changed. However, previous work has
shown that α-toxin production is reduced in a virR mu-
tant [12]. Closer inspection of the RNA-seq data showed
that the plc gene did show weakly reduced expression
(1.8-fold reduced expression; FDR = 0.04). Therefore,
QRT-PCR was employed to further examine plc gene ex-
pression. The QRT-PCR confirmed that plc was down-
regulated in the virR mutant compared to the wild type
(Fig. 2a; 2.2-fold change, P < 0.05).
For validation of the revR RNA-seq expression data,
QRT-PCR was performed on the pfoA, plc, nirC and
Fig. 1 Relative gene expression of the virR and revR mutants compared to the wild type. Strand-specific RNA-seq libraries of the wild-type strain
JIR325 and its virR and revR mutants were generated from RNA extracted from each strain. Comparative transcriptomic analysis was carried out
and differentially expressed genes in the a virR and b revR mutants were identified using the “DESeq” R package. In the MA (log ratios versus
mean average) plots that are shown, each point represents a gene. Red dots represent genes with a significant change in expression with a cutoff
of FDR > 0.01 and an absolute log2 fold change > 1. Black dots denote genes with a fold change that is not within the range of the set cutoff.
The “Y” axis represents the log2 fold change compared to the wild type and the “X” axis is the average log2 normalized counts in two
independent biological replicates
Fig. 2 QRT-PCR validation of selected genes in the virR and revR mutants. RNA was extracted from cells grown in TPG broth for 5 h,
which corresponded to the late logarithmic growth phase. RNA was converted to cDNA using reverse transcriptase, and was subsequently used as the
template in QRT-PCR, which was performed to validate the relative expression of the pfoA, ccp, plc, and cspB genes in the virR mutant (a)
and the expression of the pfoA, plc, nirC and cspB genes in the revR mutant (b). Expression levels are shown relative to the expression of
the housekeeping gene, rpoA, and are the average of at least three independent biological replicates (n ≥ 3, mean ± SEM). The asterisk (*)
denotes a statistically significant difference (p ≤ 0.05) as calculated with the student’s unpaired t-test
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cspB genes (Fig. 2b). These genes were selected as they
represented genes whose expressions were either un-
changed (pfoA, plc), down-regulated (nirC) or up-
regulated (cspB) in the revR mutant. The QRT-PCR
results (Fig. 2b) were in agreement with, and thereby
validated, the RNA-seq data.
Functional classification of differentially expressed genes
To allow functional analysis of the differentially
expressed genes, they were classified into specific Gene
Ontology (GO) groups [34] and pathways using the
Kyoto Encyclopedia of Genes and Genomes (KEGG)
[35]. These analyses indicated that many genes encoding
components involved in sporulation and developmental
processes were differentially expressed in the virR
mutant (Fig. 3a), while genes encoding proteins asso-
ciated with metabolite transport systems and mem-
brane integrity were differentially expressed in the
revR mutant (Fig. 3b).
Genes encoding proteins within the hyaluronidase/colla-
genase/cell adhesion functional category were significantly
over-represented in the differentially expressed genes sets
for both the virR and revR mutants (Fig. 3). In the virR
mutant, the genes encoding NagH, NanJ, CPE0818
(Endo-beta-N-acetylglucosaminidase), CPE0866 (alpha
N-acetylglucosaminidase), NagJ, NagL, a sialidase-
like-protein (CPE1264), and a hypothetical protein
(CPE1364) showed increased expression, whereas in
the revR mutant genes encoding NagH, NanJ, NagJ,
NagL, CPE0866, NagI and the hypothetical protein
(CPE1876) showed reduced expression.
Several genes are regulated by both VirR and RevR
To reveal the distinctive roles of VirR and RevR, we iden-
tified genes that were regulated by only one or both of
these response regulators. More genes were regulated
solely by VirR (183) than by RevR (44) (Fig. 4). Genes en-
coding ferredoxin (CPE2511 and CPE1065), PTS system
proteins (CPE2629, CPE2631 and CPE2632) and more
than 30 sporulation-related proteins are examples of the
genes that were regulated only by VirR (Additional file 2:
Table S2). Genes encoding putative ABC transporters
(CPE2031, CPE2081, CPE2082, and CPE0576-0578), a
transcriptional repressor (CtsR), and a signal peptidase
type I (CPE2295) were among the genes that were regu-
lated only by RevR (Additional file 3: Table S3).
By contrast, 23 chromosomal genes were regulated by
both VirR and RevR (Table 1). Eighteen of these genes
were expressed at higher levels in the virR mutant and
at lower levels in the revR mutant compared to the wild
type (Table 1) (Fig. 4). Functional characterization of
these 18 genes showed that they encoded proteins that
were clustered into a few functional groups, namely pro-
teins with fibronectin type III domains (CPE0818 and
CPE1875), several extracellular hydrolytic enzymes
(NagH, NanJ, NagJ and NagL), sporulation-associated
proteins (SigF, FtsN, SpoIIIAG, SigG and SpoIVA), galac-
toside transporters (MglB, MglA and MglC) and three
hypothetical proteins (Table 1). PSI-BLAST searches and
InterProScan analysis of the hypothetical proteins
showed that CPE2262 and CPE0554 contained a metal-
loprotease domain and that CPE2261 was a putative
extracellular solute binding protein that may function in
the initiation of sensory transduction pathways.
Fig. 3 Gene Ontology (GO) and KEGG enrichment analysis. Bar charts denote the log10 FDR (False Discovery Rate) of over-represented GO (grey)
and KEGG (black) categories in the a virR and b revR mutants as identified by the “Goseq” Bioconductor package. Abbreviations: RNA BTFA: RNA
polymerase binding transcription factor activity; PTTA: phosphate transmembrane transporter activity
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Four genes were regulated by both VirR and RevR
in the same manner: cspB, rubY, fruA and pstC
(Table 1). The cspB and rubY genes were expressed at
higher levels in both mutants, whereas the fruA and
pstC genes were expressed at lower levels compared
to the wild type (Table 1). These results suggested
that VirR and RevR have both common and distinct
functional roles in C. perfringens.
VirR and RevR regulate genes located on the native
plasmid, pCP13
Strains 13 and its derivatives harbor the 54.3 kb plasmid
pCP13, which carries a β2-toxin gene, cpb2 [36]. The
VirSR regulatory system, via its secondary regulator, VR-
RNA, is known to regulate the expression of two
pCP13-encoded genes, cpb2 and cnaB [37]. To further
explore the role of VirR and RevR in the regulation of
plasmid genes, the RNA-seq reads were also mapped to
the 63 genes on pCP13.
The transcription of 47 of the 63 pCP13 genes was al-
tered in the virR mutant (Additional file 5: Table S4). By
contrast, only seven plasmid-encoded genes, including
Fig. 4 Genes that were regulated by both VirR and RevR. The Venn
diagram generated with Vennt software represents the number of
genes that were regulated by VirR (183; blue), RevR (44; pink) or both
(23; purple). The 18 genes that were controlled by both regulators
are indicated. The five genes that were regulated in a similar manner
by VirR and RevR are not listed here
Table 1 Genes regulated by both VirR and RevR




Extracellular enzyme cpe0191 nagH hyaluronidase 2.07 −1.77
cpe0553 nanJ sialidase 2.15 −3.41
cpe1234 nagJ hyaluronidase 1.90 −2.10
cpe1523 nagL hyaluronidase 1.44 −2.07
Sporulation proteins cpe2048 sigF sporulation sigma factor 1.98 −1.98
cpe2146 ftsN Sporulation/cell division protein 1.56 −2.09
cpe1827 spoIIIAG sporulation protein AG 3.02 −4.03
cpe1761 sigG sporulation sigma factor 2.73 −2.06
cpe1753 spoIVA sporulation protein A 2.73 −2.44
Galactoside transporters cpe1341 mglB galactoside ABC transporter 2.42 −3.90
cpe1342 mglA galactoside ABC transporter 2.70 −3.71
cpe1343 mglC galactoside ABC transporter 2.69 −4.36
Fibronectin III domain proteins cpe1875 cpe1875 fibronectin/fucosidase 1.40 −1.84
cpe0818 cpe0818 endo-beta-N-acetylglucosaminidase 1.63 −2.26
Hypothetical proteins cpe1257 ugpB ABC transporter substrate binding protein 1.47 −3.51
cpe0554 cpe0554 camelysin-like protein 2.45 −3.25
cpe2262 cpe2262 has a camelysin M73 family peptidase domain 1.46 −2.20
cpe2261 cpe2261 hypothetical protein 1.53 −1.93
Othersb cpe2562 cspB protease 3.87 4.49
cpe0855 rubY rubrerythrin 1.42 1.66
cpe0584 fruA PTS fructose transporter −1.48 −1.83
cpe0638 pstC phosphate ABC transporter permease −1.27 −6.50
cpe0094 nirC nitrite transporter −1.75 −5.13
aAs defined by FDR <0.01; log2 fold change > 1
bGenes that are regulated by VirR and RevR in the same manner
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cnaB, were found to be positively regulated by RevR
(FDR <0.01, log2 fold change > 1) (Additional file 6:
Table S5). Analysis of the transcripts of all of the pCP13
genes by RNA-seq showed that the majority of the
plasmid-encoded genes were expressed at lower levels in
the virR and revR mutants, with the virR mutation hav-
ing a greater effect on gene expression than the revR
mutation (Fig. 5a). This observation was not due to
pCP13 plasmid loss or instability, as the expression of a
control gene, pcp43, was validated using QRT-PCR and
showed statistically similar expression in the wild type
and mutant strains (Fig. 5b). QRT-PCR validation was
also performed on the cnaB, pcp17 and parB transcripts.
The results correlated with the RNA-seq data, which
showed decreased expression of the cnaB gene in both
mutants. The pcp17 and parB genes, were down-
regulated in the virR mutant, but their expression was
not statistically different in the revR mutant (Fig. 5b).
VirR and RevR regulate novel unannotated transcripts
VirR regulates many genes by activating the transcrip-
tion of sRNAs such as VR-RNA, VirT and VirU [13, 21].
To identify other potential sRNAs that may be regulated
by VirR or RevR, the RNA-seq reads from each strain
were mapped against the C. perfringens genome and an-
alyzed by visual inspection in the Artemis genome
viewer. A number of putative sRNAs were identified as
strongly transcribed sections within intergenic regions.
Importantly, the known VirR-regulated sRNAs, VR-
RNA, VirT and VirU, had low or no detectable expres-
sion in the virR mutant compared to the wild type
(Fig. 6), confirming previous studies [21, 38] and validat-
ing this approach.
Detailed analysis of the genome–wide transcript data
identified 93 transcripts that were longer than 30 nucle-
otides and located within intergenic regions. They were
designated SR1 to SR93 (Additional file 7: Table S6). To
confirm expression of these putative sRNAs, four tran-
scripts were selected for validation by RT-PCR (Fig. 7)
and one by Northern blot analysis (Fig. 8). These sRNAs
were chosen based on their location near putative
virulence-related genes, as sRNAs often regulate the ex-
pression of adjacent genes [39].
RT-PCR was carried out using RNA purified from 5 h
cultures of the wild-type strain JIR325, the virR and revR
mutant strains to replicate the conditions of the RNA-
seq analysis. The signals of the selected sRNAs on the
wild-type depth of coverage plot were used to estimate
the size of each sRNA. RT-dependent transcripts with
the predicted sizes (Fig. 7a-e) were detected using spe-
cific primer pairs spanning SR14, SR16, SR42, SR50 and
SR73 in both wild-type and mutant strains. The absence
of products in the no RT reactions confirmed that the
products were not derived from DNA contamination.
One of the four sRNAs, SR73, was also analyzed by
Northern blotting (Fig. 8). Two transcripts, 0.85 kb and
0.25 kb in size, hybridized with the SR73-specific probe
(Fig. 8). The faint 0.85 kb transcript was only observed
in the RNA samples isolated during early growth phase
(1 and 2 h), indicating that SR73 (0.25 kb) was co-
transcribed with the downstream gene, cpe2167
(0.60 kb) during this growth phase. The 0.25 kb band
(SR73) was observed in increasing intensity in the RNA
preparations from mid- and late-logarithmic phases (3, 4
and 5 h). By contrast, the 0.85 kb band (SR73 and
cpe2167) was detected only during the early logarithmic
phase (1 and 2 h). Bioinformatic analysis of the SR73
coding sequence indicated that SR73 was a putative
Flavin mononucleotide (FMN) riboswitch. Its location
upstream of cpe2167, in conjunction with the North-
ern blot results implied that SR73 could potentially
repress the expression of cpe2167 through the
Fig. 5 Relative expression of pCP13 genes in the virR and revR mutants compared to the wild type. a The expression levels of all plasmid-encoded
genes in the virR (blue) and revR (red) mutants. Note that no FDR and fold-change cutoff criteria were applied to the data represented
here. b Real-time PCR was performed to validate differentially expressed pCP13 plasmid genes in the virR and revR mutants. Expression
levels were relative to the expression of the housekeeping gene, rpoA, and were the average of at least three independent biological
replicates (n ≥ 3, mean ± SEM). The asterisk (*) denotes a statistically significant difference (p ≤ 0.05) as calculated with the student’s
unpaired t-test
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formation of a premature terminator during mid- to
late- logarithmic growth phase.
The intergenic transcripts (SR1 to SR93) that were
potentially regulated by VirR and RevR were also
identified by performing comparative analysis of the
RNA-seq data. In the virR mutant, only two sRNAs,
SR45 and SR67, were up-regulated compared to the
wild type, while in the revR mutant, four sRNAs, SR7,
SR27, SR77 and SR82, were significantly down-
regulated (Table 2 & Additional file 3: Table S3).
These results indicated that in the wild-type strain the ex-
pression of SR45 and SR67 was usually repressed by VirR
and that the expression of SR7, SR27, SR77 and SR82 was
normally activated by RevR.
Discussion
In this study, we have used strand-specific RNA-seq to
investigate the transcription of genes in a gas gangrene-
causing isolate of C. perfringens. In particular, we ana-
lyzed gene expression in the virR and revR regulatory
mutants compared to the wild type. Through this ana-
lysis, we have identified a subset of genes that are regu-
lated by both response regulators, but in a reciprocal
manner. VirR was found to repress the expression of
these genes, while RevR enhanced their expression. The
proteins encoded by these genes can be classified into
the extracellular enzymes, sporulation proteins and ga-
lactoside transporters functional groups. Both VirR and
RevR may be independently repressing and enhancing
the expression of these genes, respectively. Alternatively,
the VirR and RevR regulatory systems may converge and
confer opposite effects on one of their common second-
ary regulators, thereby leading to opposite outcomes on
the expression of the target genes. The reciprocal regula-
tion of genes has been described in Pseudomonas aerugi-
nosa [40, 41], where multiple regulatory systems exert
opposite effects on the expression of the sRNA RsmZ
and therefore cause different downstream consequences
to the RsmZ target genes [40].
Previous studies suggested that the VirR and RevR
regulatory cascades were stimulated by different external
signals. The signal that was proposed to activate the
VirSR system is the AgrD-derived quorum sensing auto-
inducer peptide (AIP) [17, 18], while the RevR regulatory
system was hypothesized to be triggered by inorganic
phosphate levels [15]. Hence, reciprocal regulation of
similar genes by VirR and RevR is unlikely to be the re-
sult of these systems responding differently to the same
signal. Moreover, it is unlikely that the VirR and RevR
pathways converge on the known sRNA molecules
(VR-RNA, VirU and VirT) that are directly regulated
by the VirSR regulatory system, since the RNA-seq
results showed that the revR mutation had no effect
on the expression of these sRNAs. Therefore, we pos-
tulate that VirR and RevR independently regulate
these genes in a reciprocal manner.
The RNA-seq results provided evidence that VirR is a
global negative regulator that represses the expression of
195 genes and enhances the expression of only 11 genes.
It is not known how VirSR negatively regulates the ex-
pression of these genes, as no VirR boxes [20] were
found in their promoter regions. Therefore, it is likely
Fig. 6 Expression levels and depth of coverage plots of VR-RNA, VirT and VirU. Depth of coverage plots of a VR-RNA (cpe0957), b VirT (cpe0845)
and c VirU (cpe0920) in the wild-type strain, and the virR and revR mutants are shown as visualized in Artemis. The genetic organization of each
sRNA is shown on the top of each figure. Mapped RNA-seq data are displayed as a plot showing sequence depth for the forward (red)
and reverse (green) strand. In the depth of coverage plots, the Y axes represent the coverage depth in reads per million mapped reads
(RPM). Expressed sRNAs are clearly seen as peaks in the depth of coverage plots
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Fig. 7 (See legend on next page.)
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that negative regulation involves a secondary intermedi-
ate like VR-RNA, since it has previously been shown
that the VirSR system regulates as many as 147 genes
through this sRNA molecule [22]. Of the 11 genes that
were positively regulated by VirR, five genes (pfoA, vrr,
virU, virT and ccp) were preceded by VirR boxes and
thus were controlled directly by the binding of VirR to
these sites [19, 20]. This result is consistent with a
previous microarray study [22]. The positive regula-
tion of the cpe0094 gene by VirR was indirect and
may be attributed to the VR-RNA molecule, as previ-
ously described [22]. How VirR positively regulates
the remaining five genes (cpe0844, purE, cpe0947,
fruA and pstC) is still unclear.
In a previous study, several virulence-associated genes
were found to be under the positive control of the
VirSR-VR-RNA cascade during the early- and mid-
logarithmic growth phase. The expression of genes in-
cluding plc, colA, nagL, nanI, nanJ, nanE and nanA was
affected by the vrr (VR-RNA) mutation [22]. By contrast,
our RNA-seq results showed that the expression of plc,
colA, nanI, nanE and nanA was unchanged in the virR
mutant, whereas nagL and nanJ were repressed by VirR
at late-logarithmic growth phase. These contrasting re-
sults may have arisen because the vrr mutation has a
more direct effect on the expression of its target genes
compared to the mutation of virR, which encodes the
positive regulator of vrr. An alternative explanation is
that the RNA samples used in both transcriptomic stud-
ies were prepared from different media and growth
phases. In addition, different analysis methods were
employed in the two studies [22].
The transcriptomic results revealed that as many as 36
sporulation-related genes were negatively regulated by
VirR (Additional file 2: Table S2). By contrast, four
sporulation-associated genes were positively controlled
by RevR (Additional file 3: Table S3). Similarly, previous
microarray analysis indicated that expression of
sporulation-related genes was affected by RevR [42].
Sporulation is a critical event in C. perfringens-mediated
food poisoning. Resistant spores enhance the survival of
the sporulating C. perfringens strains in the small intes-
tine [43] and the enterotoxin (CPE) that is produced
during sporulation has been shown to cause the
symptoms of acute food poisoning [44, 45]. However, C.
perfringens strain 13 is a CPE-negative gas gangrene
strain that has a low sporulation efficiency [46]. It has
been proposed that the absence of the spore coat pro-
teins CotJB and CotJC, or the presence of a premature
stop codon in the master sporulation regulatory gene
spo0A, is responsible for the sporulation defect in this
strain [36]. We have shown that the expression of sporu-
lation genes was affected by the virR mutation, including
genes encoding spore maturation proteins (SpoA/B),
stage II to V proteins and sporulation sigma factors
(SigF, SigG and SigK). The revR mutation also affected
the expression of some sporulation-related genes, albeit
to a lesser extent. Of these genes, sigF and sigG were sig-
nificantly downregulated in the revR mutant, suggesting
that these genes are normally activated by RevR. Note
that the virR mutation has the opposite effect on these
genes. These two sigma factors have been shown to be
essential for sporulation, with SigF being critical for
CPE production [43]. A VirR-independent sRNA,
VirX, has also been reported to negatively regulate
the expression of sporulation sigma factor genes, in-
cluding sigE, sigF and sigK, and mutation of virX
leads to an increase in sporulation and CPE produc-
tion in the food-poisoning strain SM101 [47]. The
RNA-seq data showed that there was no significant
difference in the expression of virX (cpe0646) in the virR
mutant compared to the wild type. Hence, VirSR may
work together with VirX to negatively regulate
sporulation-related genes in sporulating C. perfringens
strains.
The RNA-seq data showed that RevR behaves pri-
marily as a positive regulator. The mechanism by
which RevR regulates its target genes is as yet un-
known. However, considering that it shares a high
level of similarity with PhoB, a response regulator in
the phosphate (Pi) signal transduction system, we pre-
viously postulated that RevR may function in a
phosphate-dependent manner [15]. In E. coli, it has
been suggested that the two-component proteins
PhoR and PhoB sense phosphate levels by monitoring
the activity of the phosphate-specific ATP-binding
cassette transporter PstSCAB [48]. The RNA-seq re-
sults showed that genes (cpe0636 – cpe0641), which
(See figure on previous page.)
Fig. 7 Validation of selected sRNA transcripts. Depth of coverage plots of a SR14, b SR16 c SR42, d SR50 and e SR73 together with their
respective genetic organization and RT-PCR results are shown. Depth of coverage plots from the RNA-seq data of the wild-type JIR325
are depicted, where red and green graphs represent transcription on the sense- and antisense-strand, respectively. The Y axes show the
coverage depth in reads per million mapped reads (RPM) and the X axes show the corresponding genetic organization. The approximate
transcript lengths are indicated in brackets. Whole genes are represented by filled arrows, while open arrows indicate partial genes. RT-PCR was carried
out to validate these unannotated transcripts. L, PCR marker ladder; 1, DNA control; 2, wild-type RNA with RT reaction; 3, wild-type RNA with no RT; 4,
virR mutant RNA with RT; 5, virR mutant RNA with no RT; 6, revR mutant RNA with RT; 7, revR mutant RNA with no RT. The estimated
sizes of the RT-PCR products (in kb) are shown on the left of the agarose gel images
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are located directly upstream of revR, and encode pu-
tative PstSCAB transporter proteins, were positively
regulated by RevR.
These data indicate that RevR controls at least 44
genes independently of VirR. Consistent with previous
findings, nagH, nanJ, nagL and cpe1753 (stage IV sporu-
lation protein A) were expressed at a lower level in the
revR mutant [15]. Other genes, including nanI, ccp and
cpe0185, which were previously found to be expressed at
a higher level in the revR mutant [15], showed no signifi-
cant change in their expression levels in the current
study. The expression of other genes also differed from
that reported in a previous study [15]. The discrepancy
may be due to different transcriptomic approaches, the
use of different media and the fact that the RNA was
isolated at different time points.
KEGG and GO analysis of the differentially expressed
genes in both mutants revealed the potential physiological
roles of the VirSR and RevR regulatory systems. However,
further experiments need to be conducted to substantiate
the proposed functions of these candidate genes and any
potential roles in virulence. Half of the GO over-
represented categories in the virR mutant were involved
in cell developmental processes that lead to changes in the
cell over time, indicating that the VirSR regulatory system
not only has a role in virulence, but also influences the
growth of C. perfringens. In the revR mutant, other than
the phosphate transmembrane transporter system, cell
membrane proteins and transporters were significantly
over-represented in the differentially regulated genes, sug-
gesting that RevR may have a major role in maintaining
membrane integrity and controlling the uptake and/or ex-
port of nutrient/ions in C. perfringens.
VirSR is one of the most important regulatory systems
in C. perfringens and this regulon has been characterized
using different approaches [21, 22, 49, 50]. However, none
of these studies addressed the transcripts within intergenic
regions or on pCP13, except for one study, which pro-
vided preliminary evidence that the VirSR system affects
the expression of the cnaB and cpb2 genes on pCP13 [37].
Microarray analysis failed to detect transcription of other
pCP13 genes [22], probably due to the low expression
levels of transcripts from these regions and the narrow dy-
namic range of the microarray technique. In this study,
comparative RNA-seq analysis showed that both VirR and
RevR alter the transcription of pCP13 genes, with VirR
having a more noticeable effect. The expression of 47
pCP13 genes was at least four times lower in the virR mu-
tant compared to the wild-type strain. It is possible that
some of these changes may be due to indirect effects of
the response regulator(s) on plasmid copy number. Previ-
ously, the cnaB and cpb2 genes were found to be nega-
tively and positively regulated, respectively, by the VirSR
system in a VR-RNA dependent manner during the mid
to late logarithmic growth phases [37]. However, the re-
sults obtained in this study indicated that both genes were
positively regulated by the VirSR regulatory system during
late logarithmic growth phase and have provided
Table 2 Differentially expressed sRNAs in the virR and revR mutants
Strain sRNA Gene 1 Product 1a,b Gene 2 Product 2a,b log2 fold change
virR mutant SR45 eutQ entanolamine utilization protein btuE glutathione peroxidase 2.19
SR67 valS valine-tRNA ligase cpe1920 hypothetical protein 1.85
revR mutant SR7 mviM dehydrogenase nirC nitrite transporter −3.74
SR27 cpe0454 membrane protein cpe0455 alkaline phosphatase-like protein −2.54
SR77 ddpA oligopeptide transporter narK nitrate extrusion protein −2.62
SR82 bglB beta-glucosidase putA aldehyde dehydrogenase −1.97
aAs defined by FDR < 0.01; log2 fold change >1
bGene 1 and gene 2 are used to designate the genes on each side on the postulated sRNA gene
Fig. 8 Time-course Northern blotting analysis of SR73. RNA was
isolated from the wild-type JIR325 cultured in TPG broth at the
indicated times (1, 2, 3, 4 and 5 h). A total of 10 μg of RNA extracted
from the wild-type strain was used in Northern blotting analysis to
examine the expression of SR73. The loading control shows the total
RNA samples that were separated by agarose gel electrophoresis and
later transferred to a Nylon membrane for Northern blot analysis. The
genes flanking SR73 are indicated as green arrows, while the yellow
bar shows the position of the SR73 probe. The probe was generated
using forward (→) and reverse (←) primers as designated in the gene
map. The hybridization of the probe to the target RNA was detected
by CDP-Star chemiluminescence. The black solid arrow marks the
transcript that hybridized to the probe and the estimated size of
the transcripts (in kb) is shown on the right of the Northern
blot image
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evidence that the VirR and RevR regulatory systems
control not only chromosomally-encoded genes, but
also the expression of plasmid-encoded genes.
It is now well established that sRNAs regulate diverse
processes in bacteria, ranging from stress adaptation to
the control of central and secondary metabolism and
virulence processes [31, 51]. By employing strand-
specific RNA-seq, we have identified 93 novel transcripts
encoded on the wild-type chromosome (Additional file
7: Table S6). Of these previously unannotated tran-
scripts, 30 corresponded to previous in silico-predicted
sRNAs of C. perfringens strain 13 [52] (Additional file 7:
Table S6), strongly supporting their approach. Compara-
tive analysis of the expression of these sRNAs in the wild
type and the mutants revealed that VirSR and RevR reg-
ulated the expression of two and four sRNAs, respect-
ively (Table 2). Note that although RNA-seq depth of
coverage plots can provide a preview of the transcription
pattern, which helps in the prediction of putative sRNAs,
Northern blots need to be conducted to confirm
whether these putative sRNAs are independent mole-
cules or read-through transcripts from close adjacent
genes. Our studies have laid the foundation for further
analysis of the sRNAs of C. perfringens. The primary
remaining challenge is to decipher the functional roles
of these putative sRNAs. These studies will identify
new regulatory systems, and will likely extend many
established signaling pathways. For example, a potential
sRNA, SR14, was identified upstream of the pfoA gene
(Fig. 7a). Sequence analysis of the potential coding re-
gion of SR14 showed that this putative sRNA was lo-
cated downstream of the VirR binding sites, the VirR
boxes, and the pfoA promoter. Although there is no ex-
perimental evidence to show that SR14 affects the ex-
pression of pfoA, the potential involvement of a sRNA
would suggest that the regulation of PFO production
may be much more complex than previously thought. Irre-
spective of the outcome of such studies, the identification
of these novel transcripts has greatly refined the annotation
of the C. perfringens genome, aiding to the current know-
ledge of this important pathogenic bacterium.
Conclusions
In summary, in this study RNA-seq was used to analyze
the transcriptional activity of C. perfringens strain JIR325
and its isogenic virR and revR mutants. The VirR and
RevR regulons include chromosomally encoded genes,
pCP13-encoded genes and previously unidentified sRNAs.
VirR was found to behave primarily as a global negative
regulator, while RevR acted as a global positive regulator.
Furthermore, our data indicate that a small subset of
genes are regulated by both the VirSR and RevR pathways.
Further investigation is needed to answer many questions
arising from this study, such as the relative importance of
the VirR and RevR pathways and the functional roles of
the novel sRNA transcripts. Nevertheless, the results re-
ported in this study have significantly enhanced our un-
derstanding of these virulence-related regulatory systems.
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